Product Details
| Product Name:
Atrosab |
CAS No.:
1365659-05-7 |
| Purity:
95.22% (SEC-HPLC) |
Supply Ability:
10g |
| Release date:
2026/07/07 |
Product Introduction
Bioactivity
| Name | Atrosab |
| Description | Atrosab is a humanized IgG1 antibody targeting TNFR1, inhibiting TNF-mediated apoptosis, and can be used to study inflammatory and neurodegenerative diseases. |
| In vitro | Binding of Atrosab to MEF-TNFR1-Fas was comparable to that of H398 as shown by a titration of antibody concentration. The EC50 values were approximately 0.1 nM for both Atrosab and H398. [1] |
| Storage | Store at low temperature
-20°C for 1 year
Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | Apoptosis |
| Inhibitors Related | Stavudine | Kaolin | Aceglutamide | Urea | Tamoxifen | Cysteamine hydrochloride | Metronidazole | Citric Acid Triammonium | Formamide | Dimethyl phthalate | Alginic acid | Sildenafil citrate |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
|
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States